Neuroscience Antibodies & Assays Market : Rising Incidence of Neurological Diseases
The global neuroscience antibodies and assays market is expected to reach USD 4.18 billion by 2023 from USD 2.57 billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. On the other hand, quality and cost concerns over the production...
Immunoassay Market | Increasing Adoption of Immunoassay-Based Point-Of-Care Testing and Rapid Testing
The immunoassays market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1%. Factors driving the growth of this market include the increasing adoption of immunoassay-based point-of-care (POC) testing and rising incidence of chronic diseases across the world.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=436
The global immunoassays...
Biomarker Technologies Market : Increasing Utility of Biomarkers for Diagnostic Purposes And Rising Biomarker Research
The global biomarker technologies market was valued at USD 46.97 billion in 2017. It is expected to reach USD 74.51 billion in 2022, at CAGR of 9.7% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=190358765
The growth of this market is mainly driven by increasing healthcare expenditure, rising R&D funding, the increasing utility of biomarkers...
Significant Opportunities for the Growth of Oncology-Based Nutrition Formulas.
The global oncology nutrition market is projected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. Factors such shift from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rise in number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional...
Opportunities of Medical Device Connectivity Market in Healthcare Industry
The global medical device connectivity market is projected to reach USD 2,670.3 million by 2023 from USD 939.4 million in 2018, at a CAGR of 23.2%. Growth in this market can be attributed to a number of factors such as the increasing penetration of EHRs & health information exchange systems in healthcare organizations, healthcare IT initiatives driving the integration of medical devices with hospital...
Growing Adoption of Open Innovation Models Dominating High Throughput Screening Market
The global high-throughput screening (HTS) market is projected to reach USD 21.69 billion by 2023 from USD 14.87 billion in 2018, at a CAGR of 7.8%. Factors such initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments are driving the growth of the...
Growing Prevalence of Animal Diseases Causing Pain and Inflammation Driving Veterinary Pain Management Market
The veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and rising adoption...
Sleep Apnea Devices Market by Type & End User – 2023
The sleep apnea devices market is projected to reach USD 6.49 billion by 2023 from an estimated USD 4.44 billion in 2018, at a CAGR of 7.8%. Growing awareness regarding the ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, and the large pool of undiagnosed and untreated sleep apnea patients are the major factors driving the growth of the market. Technological advancements...
High Potency APIs /HPAPI Market Booming Trends and Forecast Assessment for the Period 2017 – 2023
The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision...
Increasing Prevalence of Infectious Diseases Drives The Growth of The Global Infectious Disease Diagnostics Market
The global infectious disease diagnostics market is projected to reach USD 19.35 billion in 2022 from USD 14.73 billion in 2017, at CAGR of 5.6%. Growth in this market will largely be driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics
Download...